BRNS $0.77 (+1.32%) Quote details
Add to Watchlist Run Backtest
Establish your trading edge with a set of smart tools for serious trades. Upgrade Account
stock

Barinthus Biotherapeutics plc

NASDAQ | BRNS

0.77

USD

+0.01 (+1.32%)

AT CLOSE (AS OF Apr 3, 2025)

$31M

MARKET CAP

-

P/E Ratio

-1.55

EPS

$3.7

52 Week High

$0.76

52 Week Low

LIFE SCIENCES

Sector

BRNS Chart

1D
Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Icon For Time-schedule

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests
Icon For Search

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals
Icon For Clipboard-list

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

BRNS Technicals

Tags:

BRNS Earnings

Yearly Income Statement (As of Dec 31, 2023)

Field Value (USD)
Gross Profit -$50M
Total Revenue $802K
Cost Of Revenue $43M
Costof Goods And Services Sold $3.1K
Operating Income -$84M
Selling General And Administrative $40M
Research And Development $45M
Operating Expenses $85M
Investment Income Net $2.9M
Net Interest Income -$28K
Interest Income $3.6M
Interest Expense $28K
Non Interest Income -$6.8M
Other Non Operating Income $1.1M
Depreciation $2.3M
Depreciation And Amortization $3.2M
Income Before Tax -$76M
Income Tax Expense -$3.1M
Interest And Debt Expense $28K
Net Income From Continuing Operations -$73M
Comprehensive Income Net Of Tax -$63M
Ebit -$76M
Ebitda -$73M
Net Income -$73M

Revenue & Profitability

Earnings Performance

BRNS Financials

yearly Balance Sheet (As of Dec 31, 2023)

Field Value (USD)
Total Assets $215M
Total Current Assets $157M
Cash And Cash Equivalents At Carrying Value $142M
Cash And Short Term Investments $142M
Inventory $1
Current Net Receivables $3M
Total Non Current Assets $57M
Property Plant Equipment $12M
Accumulated Depreciation Amortization Ppe $3.7M
Intangible Assets $37M
Intangible Assets Excluding Goodwill $25M
Goodwill $12M
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $1.5M
Other Non Current Assets -
Total Liabilities $28M
Total Current Liabilities $13M
Current Accounts Payable $1.6M
Deferred Revenue $0
Current Debt -
Short Term Debt $1.8M
Total Non Current Liabilities $26M
Capital Lease Obligations $13M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $13M
Other Current Liabilities $9.2M
Other Non Current Liabilities $1.3M
Total Shareholder Equity $187M
Treasury Stock -
Retained Earnings -$177M
Common Stock $1K
Common Stock Shares Outstanding $39M

yearly Cash Flow (As of Dec 31, 2023)

Field Value (USD)
Operating Cashflow -$51M
Payments For Operating Activities $639K
Proceeds From Operating Activities -
Change In Operating Liabilities -$3.8M
Change In Operating Assets -$8.1M
Depreciation Depletion And Amortization $5.4M
Capital Expenditures $5.4M
Change In Receivables -$5.8M
Change In Inventory -
Profit Loss -$73M
Cashflow From Investment -$5.4M
Cashflow From Financing $1.9M
Proceeds From Repayments Of Short Term Debt $0
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock $2M
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $2M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$73M

yearly Income Statement (As of Dec 31, 2023)

Field Value (USD)
Gross Profit -$50M
Total Revenue $802K
Cost Of Revenue $43M
Costof Goods And Services Sold $3.1K
Operating Income -$84M
Selling General And Administrative $40M
Research And Development $45M
Operating Expenses $85M
Investment Income Net $2.9M
Net Interest Income -$28K
Interest Income $3.6M
Interest Expense $28K
Non Interest Income -$6.8M
Other Non Operating Income $1.1M
Depreciation $2.3M
Depreciation And Amortization $3.2M
Income Before Tax -$76M
Income Tax Expense -$3.1M
Interest And Debt Expense $28K
Net Income From Continuing Operations -$73M
Comprehensive Income Net Of Tax -$63M
Ebit -$76M
Ebitda -$73M
Net Income -$73M

BRNS Profile

Barinthus Biotherapeutics plc Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

Barinthus Biotherapeutics plc, a clinical-stage biopharmaceutical company, engages in developing novel T cell immunotherapeutics to guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company is headquartered in Harwell, the United Kingdom.

DMN
9.42%
$0.0151
NVDA
-7.81%
$101.8
INTC
2.05%
$22.43
F
-5.96%
$9.545
LCID
-3.33%
$2.32
STSS
8.79%
$0.0297
PTIX
84.14%
$0.418
LGMK
-15.96%
$0.0158
TSLA
-5.47%
$267.28
BAC
-11.21%
$37.16
NIVF
-4.75%
$0.561
MGOL
-20.43%
$0.37
DGLY
9.09%
$0.036
AAPL
-9.25%
$203.19
PLTR
-4.40%
$83.6
ALTM
0.00%
$5.84
OSRH
68.03%
$2.47
LILM
-36.97%
$0.052
AAL
-10.25%
$9.505
APVO
44.20%
$1.99
SOFI
-13.57%
$10.64
BON
-12.81%
$0.0633
NKE
-14.59%
$55.485
BTE
-10.54%
$1.995
GNPX
46.31%
$0.4316
HOOD
-10.36%
$38.26
DNN
-4.23%
$1.245
MULN
-22.82%
$0.0795
LYT
-16.78%
$0.0982
BBD
2.93%
$2.285
AMZN
2.00%
$196.01
MRM
87.76%
$0.6947
PFE
-1.66%
$24.29
VALE
-3.52%
$9.735
BTG
-0.17%
$2.915
PCSA
-27.18%
$0.3
PMAX
-2.68%
$0.435
SNAP
-9.74%
$8.015
AMD
-8.90%
$93.8
PLUG
-8.33%
$1.21
T
1.60%
$28.59
JYD
21.48%
$0.4197
ABEV
2.12%
$2.41
GOOGL
-4.02%
$150.72
WBD
-12.78%
$9.21
SMCI
-7.89%
$32.32
CCL
-13.71%
$17.275
MU
-16.09%
$74.34
AVGO
-10.51%
$154.01
RIG
-14.08%
$2.715
LYG
-4.56%
$3.665
CSCO
-7.30%
$57.31
C
-12.17%
$63.03
RIVN
-7.69%
$11.53
JBLU
-17.36%
$4.165
AGNC
-1.48%
$9.34
NKLA
-28.74%
$0.183
KSS
-22.79%
$6.64
NIO
-1.32%
$3.75
ITUB
2.71%
$5.68
UAA
-18.79%
$5.36
HPE
-15.23%
$13.665
TIVC
49.85%
$4.87
VFC
-28.80%
$11.67
META
-8.96%
$531.62
AMCR
-2.50%
$9.555
CLF
-16.90%
$7.255
WMT
-2.83%
$87.22
IQ
-4.57%
$2.09
STLA
-9.36%
$10.215
FCX
-12.28%
$33.51
VRN
-6.06%
$6.275
QBTS
-2.72%
$7.14
ET
-6.31%
$17.735
BABA
-0.30%
$129.4
ME
-21.26%
$0.6063
CUTR
-10.19%
$0.0969
RGTI
-4.00%
$8.15
MCHP
-16.80%
$40.71
ERIC
-3.98%
$7.48
NCLH
-16.41%
$16.3
GOOG
-3.92%
$152.63
TSM
-7.63%
$157.395
GRAB
-7.59%
$4.26
HBAN
-11.11%
$13.52
APLD
2.46%
$6.24
CRWV
-12.32%
$53.8
NOK
-6.82%
$4.985
MARA
-9.58%
$11.23
BCS
-9.02%
$14.32
PCG
-0.98%
$17.26
FSM
-2.64%
$6.075
CX
-2.43%
$5.5518
MRVL
-12.00%
$55.64
KO
2.59%
$73.18
OXY
-11.01%
$43.9
VZ
2.03%
$45.6469
PINS
-12.35%
$27.505
GAP
-20.26%
$17.845
W
-25.47%
$25.13
DMN
9.42%
$0.0151
NVDA
-7.81%
$101.8
INTC
2.05%
$22.43
F
-5.96%
$9.545
LCID
-3.33%
$2.32
STSS
8.79%
$0.0297
PTIX
84.14%
$0.418
LGMK
-15.96%
$0.0158
TSLA
-5.47%
$267.28
BAC
-11.21%
$37.16
NIVF
-4.75%
$0.561
MGOL
-20.43%
$0.37
DGLY
9.09%
$0.036
AAPL
-9.25%
$203.19
PLTR
-4.40%
$83.6
ALTM
0.00%
$5.84
OSRH
68.03%
$2.47
LILM
-36.97%
$0.052
AAL
-10.25%
$9.505
APVO
44.20%
$1.99
SOFI
-13.57%
$10.64
BON
-12.81%
$0.0633
NKE
-14.59%
$55.485
BTE
-10.54%
$1.995
GNPX
46.31%
$0.4316
HOOD
-10.36%
$38.26
DNN
-4.23%
$1.245
MULN
-22.82%
$0.0795
LYT
-16.78%
$0.0982
BBD
2.93%
$2.285
AMZN
2.00%
$196.01
MRM
87.76%
$0.6947
PFE
-1.66%
$24.29
VALE
-3.52%
$9.735
BTG
-0.17%
$2.915
PCSA
-27.18%
$0.3
PMAX
-2.68%
$0.435
SNAP
-9.74%
$8.015
AMD
-8.90%
$93.8
PLUG
-8.33%
$1.21
T
1.60%
$28.59
JYD
21.48%
$0.4197
ABEV
2.12%
$2.41
GOOGL
-4.02%
$150.72
WBD
-12.78%
$9.21
SMCI
-7.89%
$32.32
CCL
-13.71%
$17.275
MU
-16.09%
$74.34
AVGO
-10.51%
$154.01
RIG
-14.08%
$2.715
LYG
-4.56%
$3.665
CSCO
-7.30%
$57.31
C
-12.17%
$63.03
RIVN
-7.69%
$11.53
JBLU
-17.36%
$4.165
AGNC
-1.48%
$9.34
NKLA
-28.74%
$0.183
KSS
-22.79%
$6.64
NIO
-1.32%
$3.75
ITUB
2.71%
$5.68
UAA
-18.79%
$5.36
HPE
-15.23%
$13.665
TIVC
49.85%
$4.87
VFC
-28.80%
$11.67
META
-8.96%
$531.62
AMCR
-2.50%
$9.555
CLF
-16.90%
$7.255
WMT
-2.83%
$87.22
IQ
-4.57%
$2.09
STLA
-9.36%
$10.215
FCX
-12.28%
$33.51
VRN
-6.06%
$6.275
QBTS
-2.72%
$7.14
ET
-6.31%
$17.735
BABA
-0.30%
$129.4
ME
-21.26%
$0.6063
CUTR
-10.19%
$0.0969
RGTI
-4.00%
$8.15
MCHP
-16.80%
$40.71
ERIC
-3.98%
$7.48
NCLH
-16.41%
$16.3
GOOG
-3.92%
$152.63
TSM
-7.63%
$157.395
GRAB
-7.59%
$4.26
HBAN
-11.11%
$13.52
APLD
2.46%
$6.24
CRWV
-12.32%
$53.8
NOK
-6.82%
$4.985
MARA
-9.58%
$11.23
BCS
-9.02%
$14.32
PCG
-0.98%
$17.26
FSM
-2.64%
$6.075
CX
-2.43%
$5.5518
MRVL
-12.00%
$55.64
KO
2.59%
$73.18
OXY
-11.01%
$43.9
VZ
2.03%
$45.6469
PINS
-12.35%
$27.505
GAP
-20.26%
$17.845
W
-25.47%
$25.13
Discover more tools and features to empower your trading
Explore Features

Quotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.